Genomics plc is a pioneering healthcare company that uses large-scale genetic information to develop innovative precision healthcare tools and to bring new understanding to drug discovery. Genomics was founded in 2014 by four world-leading statistical and human geneticists at the University of Oxford. Today, Genomics is collaborating with some of the world’s leading healthcare and drug-discovery organizations and helping them to predict, prevent, treat and cure – dramatically reducing the human and financial cost of common diseases like cancer and diabetes.
“Let’s Turn These Words into Action”: Bayer’s Shobhna Ladva Passionately Calls for Real Change in Women’s Health
Representing Bayer at Speaker’s House, Shobhna Ladva highlighted the urgent need for policy reform, education, and empowerment in women’s health – calling on government and partners to act now.
